These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 11697712)

  • 1. Plasma fibrinogen level is an important determinant of prolonged euglobulin clot lysis time in hemodialysis patients.
    Borawski J; Myśliwiec M
    Clin Appl Thromb Hemost; 2001 Oct; 7(4):296-9. PubMed ID: 11697712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The significant enhancement of fibrinolysis by calcium ion in a cell free system: the shortening of euglobulin clot lysis time by calcium ion.
    Kojima Y; Urano T; Kojima K; Serizawa K; Takada Y; Takada A
    Thromb Haemost; 1994 Jul; 72(1):113-8. PubMed ID: 7974358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Euglobulin clot lysis time reveals a high frequency of fibrinolytic activation in trauma.
    Ilich A; Kumar V; Ferrara MJ; Henderson MW; Noubouossie DF; Jenkins DH; Kozar RA; Park MS; Key NS
    Thromb Res; 2021 Aug; 204():22-28. PubMed ID: 34111811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inactivation of plasminogen activator inhibitor type 1 by activated factor XII plays a role in the enhancement of fibrinolysis by contact factors in-vitro.
    Tanaka A; Suzuki Y; Sugihara K; Kanayama N; Urano T
    Life Sci; 2009 Jul; 85(5-6):220-5. PubMed ID: 19500599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PAI-1 plays an important role in the expression of t-PA activity in the euglobulin clot lysis by controlling the concentration of free t-PA.
    Urano T; Sumiyoshi K; Pietraszek MH; Takada Y; Takada A
    Thromb Haemost; 1991 Oct; 66(4):474-8. PubMed ID: 1796399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrinogen, coagulation factor VII, tissue plasminogen activator, plasminogen activator inhibitor-1, and lipid as cardiovascular risk factors in chronic hemodialysis and continuous ambulatory peritoneal dialysis patients.
    Tomura S; Nakamura Y; Doi M; Ando R; Ida T; Chida Y; Ootsuka S; Shinoda T; Yanagi H; Tsuchiya S; Marumo F
    Am J Kidney Dis; 1996 Jun; 27(6):848-54. PubMed ID: 8651250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new device for measurement of fibrin clot lysis: application to the euglobulin clot lysis time.
    Boudjeltia KZ; Cauchie P; Remacle C; Guillaume M; Brohée D; Hubert JL; Vanhaeverbeek M
    BMC Biotechnol; 2002 May; 2():8. PubMed ID: 11985782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attenuation by prolonged nitric oxide synthase inhibition of the enhancement of fibrinolysis caused by environmental stress in the rat.
    Kawabata A; Hata T
    Br J Pharmacol; 1996 Sep; 119(2):346-50. PubMed ID: 8886419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrinolysis during normal human pregnancy: complex inter-relationships between plasma levels of tissue plasminogen activator and inhibitors and the euglobulin clot lysis time.
    Wright JG; Cooper P; Astedt B; Lecander I; Wilde JT; Preston FE; Greaves M
    Br J Haematol; 1988 Jun; 69(2):253-8. PubMed ID: 3134043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Changes in hemostasis and fibrinolysis in gestational diabetes].
    Kvasnicka J; Bendl J; Zivný J; Umlaufová A; Maslowská H
    Cas Lek Cesk; 1996 Feb; 135(4):106-10. PubMed ID: 8625379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrinolytic activity in retinal vein occlusion.
    Abu El-Asrar AM; Abdel Gader AG; Al-Amro S; Al-Momem AK
    Int Ophthalmol; 1997-1998; 21(6):343-8. PubMed ID: 9869344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activated protein C attenuates coagulation-associated over-expression of fibrinolytic activity by suppressing the thrombin-dependent inactivation of PAI-1.
    Urano T; Castellino FJ; Ihara H; Suzuki Y; Ohta M; Suzuki K; Mogami H
    J Thromb Haemost; 2003 Dec; 1(12):2615-20. PubMed ID: 14675098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A metabolic syndrome independent association between overweight, fibrinolysis impairment and low-grade inflammation in young women with venous thromboembolism.
    Salobir B; Sabovic M
    Blood Coagul Fibrinolysis; 2006 Oct; 17(7):551-6. PubMed ID: 16988550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue plasminogen activator as a hemodialysis catheter locking solution.
    McGill RL; Spero JA; Sysak JC; Sandroni SE; Marcus RJ
    Hemodial Int; 2008 Jul; 12(3):348-51. PubMed ID: 18638092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The euglobulin clot lysis time, a rapid and sensitive method for the assay of fibrinolytic activity after venous stasis.
    Nordby E; Arnesen H; Andersen P; Godal HC
    Scand J Haematol; 1980 Nov; 25(5):407-11. PubMed ID: 7221476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new euglobulin clot lysis assay for global fibrinolysis.
    Smith AA; Jacobson LJ; Miller BI; Hathaway WE; Manco-Johnson MJ
    Thromb Res; 2003; 112(5-6):329-37. PubMed ID: 15041279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Levels of tissue-type plasminogen activator (T-PA), its inhibitor (PAI-1) and fibrinogen in the blood of patients with type 1 and 2 diabetes mellitus].
    Kvasnicka J; Skrha J; Perusicová J; Maslowská H; Pochopová L
    Cas Lek Cesk; 1996 Mar; 135(6):174-7. PubMed ID: 8681360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The 125I-fibrinogen euglobulin clot-lysis test.
    Horvath AE; Gralnick HR
    Am J Clin Pathol; 1978 Aug; 70(2):271-4. PubMed ID: 696685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation and inhibition of fibrinolysis in septic patients in an internal intensive care unit.
    Voss R; Matthias FR; Borkowski G; Reitz D
    Br J Haematol; 1990 May; 75(1):99-105. PubMed ID: 1695855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of intrinsic fibrinolytic system activation in pathogenesis of hemostasis disturbances in hemodialyzed patients with chronic renal failure.
    Bronisz M; Rość D; Bronisz A; Manitius J; Nartowicz E
    Ren Fail; 2004 May; 26(3):223-9. PubMed ID: 15354969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.